Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00
Provider: Market Edge
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

E. I. du Pont de Nemours and Co's Danisco Wins European Patent Office Appeal As Board Revokes Novozymes Animal Feed Patent


Friday, 6 Jul 2012 02:00am EDT 

E. I. du Pont de Nemours and Co announced that in a ruling favoring Danisco, on June 29, the Technical Board of Appeal at the European Patent Office (EPO) revoked Novozymes’ animal feed enzyme patent, European Patent 1,804,592 (EP'592), in entirety throughout Europe. The Novozymes’ patent that was revoked involves a process of manufacturing an animal feed composition by steam pelleting which contains salt-coated enzyme granules. This revocation restores the ability of Danisco which DuPont acquired in May 2011, to engage in commercial activities in Europe and provide customers with solutions in the animal feed business. The patent was originally revoked by the EPO’s Opposition Division on July 7, 2011, but Novozymes appealed that decision to the Technical Board of Appeal. Novozymes had tried to enforce the EP'592 patent against Danisco in Denmark, the Netherlands, United Kingdom and Germany, but due to this revocation, it is expected that those lawsuits will either be dismissed or withdrawn. In addition, Danisco is expected to recover its legal costs. Danisco will also seek compensation for the damage caused by a preliminary injunction originally obtained by Novozymes in Denmark. On May 25, 2012, before the Technical Board of Appeal revoked the EP'592 patent, the Eastern High Court in Copenhagen had revoked that preliminary injunction and ordered Novozymes to pay Danisco DKK1.5 million (Danish krone) in legal costs. 

Company Quote

56.072
0.142 +0.25%
21 May 2013